Principal Securities, Inc. Intra Cellular Therapies, Inc. Transaction History
Principal Securities, Inc.
- $3.63 Trillion
- Q2 2024
A detailed history of Principal Securities, Inc. transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Principal Securities, Inc. holds 254 shares of ITCI stock, worth $18,666. This represents 0.0% of its overall portfolio holdings.
Number of Shares
254
Previous 255
0.39%
Holding current value
$18,666
Previous $17.6 Million
1.42%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ITCI
# of Institutions
400Shares Held
87.2MCall Options Held
309KPut Options Held
302K-
Vanguard Group Inc Valley Forge, PA9.61MShares$706 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$465 Million0.01% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.72MShares$273 Million1.37% of portfolio
-
Jpmorgan Chase & CO New York, NY3.44MShares$252 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY3MShares$220 Million2.8% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $6.94B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...